Filing Details
- Accession Number:
- 0001209191-13-036628
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-15 16:10:41
- Reporting Period:
- 2013-07-11
- Filing Date:
- 2013-07-15
- Accepted Time:
- 2013-07-15 16:10:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1554979 | E Megan Pace | C/O Vertex Pharmaceuticals Incorporated 130 Waverly St. Cambridge MA 02139 | Svp, Corp. Communications | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-07-11 | 5,000 | $38.80 | 22,949 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-07-11 | 5,000 | $84.00 | 17,949 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-07-12 | 5,000 | $38.80 | 22,949 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-07-12 | 678 | $85.00 | 22,271 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-07-12 | 5,000 | $86.00 | 17,271 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2013-07-11 | 5,000 | $0.00 | 5,000 | $38.80 |
| Common Stock | Stock Option | Disposition | 2013-07-12 | 5,000 | $0.00 | 5,000 | $38.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,750 | 2021-02-02 | No | 4 | M | Direct | |
| 8,750 | 2021-02-02 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1.
- The option vests in 16 quarterly installments from 02/03/2011.
Billionaire Hedge Funds
